Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease.
Fumiaki
F
Mori
Kunikazu
K
Tanji
Yasuko
Y
Toyoshima
Mari
M
Yoshida
Akiyoshi
A
Kakita
Hitoshi
H
Takahashi
Koichi
K
Wakabayashi
D001927:Brain Diseases / Q000378:metabolism* / Q000473:pathology*; D018797:Cell Cycle Proteins; D005625:Frontal Lobe / Q000473:pathology*; D006801:Humans; D006816:Huntington Disease; D045586:Intranuclear Inclusion Bodies / Q000473:pathology*; D017827:Machado-Joseph Disease; D026901:Membrane Transport Proteins; D020191:Myoclonic Epilepsies, Progressive; D019636:Neurodegenerative Diseases; D009474:Neurons / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism; D011180:Postmortem Changes; D020754:Spinocerebellar Ataxias; D035582:Transcription Factor TFIIIA / Q000378:metabolism*
D018797:Cell Cycle Proteins; D026901:Membrane Transport Proteins; C409460:OPTN protein, human; D010455:Peptides; D035582:Transcription Factor TFIIIA; C097188:polyglutamine